首页> 外文期刊>Kemija u industriji >Biocatalysis for the Production of Pharmaceutical Intermediates: Statin Precursors
【24h】

Biocatalysis for the Production of Pharmaceutical Intermediates: Statin Precursors

机译:生物催化生产医药中间体:他汀前体

获取原文
           

摘要

The application of enzymes in chemical synthesis, due to the recent advances, has a strong impact in multiple industries, especially the pharmaceutical industry. Namely, the use of enzymes shows remarkable advantages over classical chemical catalysis and therefore it is considered a ‘green’ solution. By using novel techniques, it is possible to tailor the enzymes to adapt them for a given process. Today, several pharmaceutical companies are successfully producing valuable precursors for the production of active pharmaceutical ingredients using enzymes, some of them being statin precursors. Statins are hypolipidemics, drugs used for the prevention of cardiovascular diseases and lowering cholesterol concentration in blood. Due to challenges in the chemical synthesis of statin intermediates, the production of statin intermediates using enzyme-catalysed reactions shows some notable advantages. Therefore, research and development laboratories, combined with reaction engineering techniques, have shifted their focus towards applying biochemical catalysis for the production of statin intermediates.
机译:由于最近的进展,酶在化学合成中的应用对多个行业,尤其​​是制药行业产生了很大的影响。也就是说,酶的使用显示出优于传统化学催化的显着优势,因此被认为是“绿色”解决方案。通过使用新技术,可以定制酶以使其适应特定过程。如今,数家制药公司正在成功地生产有价值的前体,以利用酶生产活性药物成分,其中一些是他汀类前体。他汀类药物是降血脂药,是用于预防心血管疾病和降低血液中胆固醇浓度的药物。由于他汀类中间体的化学合成方面的挑战,使用酶催化反应生产他汀类中间体显示出一些显着的优势。因此,研究与开发实验室结合反应工程技术,已将其重点转移到将生物化学催化用于他汀类中间体的生产上。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号